Watson Gets First FDA OK To Make Product At Goa, India, Plant (India)
This article was originally published in PharmAsia News
Executive Summary
Watson Pharmaceuticals Inc. received its first Food and Drug Administration product approval at its Goa, India, facility. The specialty pharmaceutical company plans to seek FDA approval in the next few months to manufacture additional solid dosage products at the facility. By early 2008, the Goa facility is expected to be producing more than 1 billion tablets and capsules annually for the U.S. market. (Click here for more - May Require Paid Subscription